Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study-Reference-Cited by-同舟云学术

Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study

Published:2024-08-01 Issue:6 Volume:34 Page:253-263
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Dinnissen Mariken¹²³^ORCID,Dietrich Andrea¹²³,Bierens Margreet⁴,van der Molen Judith H.¹,Verhallen Anne M.¹,Overbeek Wieske A.⁵,van den Hoofdakker Barbara J.¹²³⁶,Roke Yvette⁵,Troost Pieter W.⁷,Buitelaar Jan K.⁴⁸,Hoekstra Pieter J.¹²³^ORCID

Affiliation:

1. Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

2. Accare Child Study Center, Groningen, the Netherlands.

3. Department of Psychiatry, The Research School of Behavioural and Cognitive Neurosciences, University of Groningen, Groningen, the Netherlands.

4. Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands.

5. GGz Central Psychiatric Center, Amersfoort, the Netherlands.

6. Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.

7. De Bascule Child and Adolescent Psychiatry Center Amsterdam, Amsterdam, The Netherlands.

8. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2023.0065

Reference39 articles.

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition, text revision). American Psychiatric Association: Washington, DC; 2000.

2. The Nisonger Child Behavior Rating Form: typical IQ version

3. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial

4. Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage Intelligence

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the Editor-in-Chief’s Desk;Journal of Child and Adolescent Psychopharmacology;2024-08-01